Obbligazioni societarie HIGH YIELD e oltre, verso frontiere inesplorate - Vol. 2

  • Aimed at rolling over three series of outstanding debt due in 2021, Teva Pharmaceutical Industries launches a $1.5B private offering Euro-denominated Senior Notes.
  • Pricing and terms have yet to be announced.
 

Users who are viewing this thread

Back
Alto